KCNAB2 Protein

KCNAB2 (Kvβ2) - Voltage-Gated Potassium Channel Beta-2 Subunit

Introduction

Kcnab2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<table class="infobox infobox-protein"> [@zhang2016]
<tr> [@liu2018]
<th class="infobox-header" colspan="2">KCNAB2 (Kvβ2)</th> [@lammel2008]
</tr> [@rudy2001]
<tr> [@vacher2008]
<td class="infobox-header" colspan="2">Voltage-Gated Potassium Channel Auxiliary Subunit</td> [@gu2015]
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>KCNAB2</td>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Voltage-gated potassium channel subunit beta-2</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[KCNAB2](/genes/kcnab2)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td><a href="https://www.uniprot.org/uniprot/P56381" target="_blank">P56381</a></td>
</tr>
<tr>
<td class="label">PDB IDs</td>
<td>1EXB, 1J70</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>37.1 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Plasma membrane, Cytoplasm</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Kv beta subunit (KCNAB)</td>
</tr>
<tr>
<td class="label">Tissue Specificity</td>
<td>Brain (high), Heart, Skeletal muscle</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

...

KCNAB2 (Kvβ2) - Voltage-Gated Potassium Channel Beta-2 Subunit

Introduction

Kcnab2 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

<table class="infobox infobox-protein"> [@zhang2016]
<tr> [@liu2018]
<th class="infobox-header" colspan="2">KCNAB2 (Kvβ2)</th> [@lammel2008]
</tr> [@rudy2001]
<tr> [@vacher2008]
<td class="infobox-header" colspan="2">Voltage-Gated Potassium Channel Auxiliary Subunit</td> [@gu2015]
</tr>
<tr>
<td class="label">Gene Symbol</td>
<td>KCNAB2</td>
</tr>
<tr>
<td class="label">Protein Name</td>
<td>Voltage-gated potassium channel subunit beta-2</td>
</tr>
<tr>
<td class="label">Gene</td>
<td>[KCNAB2](/genes/kcnab2)</td>
</tr>
<tr>
<td class="label">UniProt ID</td>
<td><a href="https://www.uniprot.org/uniprot/P56381" target="_blank">P56381</a></td>
</tr>
<tr>
<td class="label">PDB IDs</td>
<td>1EXB, 1J70</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>37.1 kDa</td>
</tr>
<tr>
<td class="label">Subcellular Localization</td>
<td>Plasma membrane, Cytoplasm</td>
</tr>
<tr>
<td class="label">Protein Family</td>
<td>Kv beta subunit (KCNAB)</td>
</tr>
<tr>
<td class="label">Tissue Specificity</td>
<td>Brain (high), Heart, Skeletal muscle</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td>
</tr>
</table>

Overview

KCNAB2 (also known as Kvβ2 or Voltage-gated potassium channel subunit beta-2) is the predominant cytoplasmic beta subunit of neuronal voltage-gated potassium (Kv) channels. It belongs to the Kv beta subunit family, which comprises auxiliary proteins that form stable complexes with Kv alpha subunits to modulate their gating properties, trafficking, and surface expression. KCNAB2 is widely expressed in the central and peripheral nervous systems, where it plays critical roles in regulating neuronal excitability, action potential repolarization, and synaptic integration @Jensen2014.

Unlike some auxiliary subunits that affect ion conduction directly, KCNAB2 primarily functions as a modulatory subunit that influences channel behavior through protein-protein interactions and post-translational modifications. It contains a conserved N-terminal T1 domain that mediates tetramerization and interaction with Kv alpha subunits, as well as a C-terminal NAD(P)-binding domain that allows for metabolic regulation of channel function @Jensen2014.

Molecular Structure

Domain Architecture

KCNAB2 exhibits a multi-domain structure that enables its diverse functional interactions:

N-terminal T1 Domain (residues 1-109): Mediates tetramerization and specific binding to Kv alpha subunits

Linker Region (residues 110-180): Flexible connection between T1 and core domains

Core Domain (residues 181-300): Contains the NAD(P)-binding site

C-terminal Region (residues 301-367): Variable region involved in cellular localization

Structural Features

The crystal structure of KCNAB2 reveals several key features:

• Tetrameric assembly: Forms homotetramers that bind to Kv channel tetramers
• NAD(P) binding pocket: Enables metabolic regulation through nucleotide binding
• Oxidation-sensitive cysteines: Allow redox regulation of channel function

Protein-Protein Interactions

KCNAB2 interacts with multiple Kv alpha subunits:

| Kv Alpha Subunit | Channel Type | Interaction Effect |
|------------------|--------------|-------------------|
| KCNA1 (Kv1.1) | Kv1.x family | Enhanced trafficking, modified gating |
| KCNA2 (Kv1.2) | Kv1.x family | Accelerated inactivation |
| KCNA4 (Kv1.4) | Kv1.x family | Altered inactivation kinetics |
| KCNB1 (Kv2.1) | Kv2.x family | Subunit-specific modulation |

Normal Physiological Function

Neuronal Excitability Regulation

In neurons, KCNAB2 plays a essential role in shaping electrical excitability:

Action Potential Repolarization: Modulates Kv channel kinetics to ensure proper repolarization

Firing Frequency Adaptation: Influences how neurons respond to sustained depolarization

Resting Membrane Potential: Contributes to maintenance of stable resting potential

Synaptic Integration: Affects temporal summation and signal processing

Channel Trafficking

KCNAB2 facilitates the forward trafficking of Kv channels to the plasma membrane. Co-expression of beta subunits significantly increases surface expression of Kv alpha subunits, ensuring proper channel density at synaptic and extrasynaptic membranes @Jensen2014.

Metabolic Regulation

The NAD(P)-binding domain allows KCNAB2 to function as a metabolic sensor. Under conditions of cellular energy stress:

• NAD(P)H binding reduces channel modulation
• Altered redox state modifies gating kinetics
• Metabolic dysfunction can lead to channel dysregulation

Role in Neurodegenerative Diseases

Alzheimer's Disease

KCNAB2 dysfunction contributes to several aspects of Alzheimer's disease pathogenesis:

Neuronal Hyperexcitability: Early in AD, neuronal networks exhibit hyperexcitability, partly due to altered Kv channel function. KCNAB2 expression is downregulated in AD brain tissue, leading to reduced outward potassium current and increased excitability @Zhang2016.

[Amyloid-Beta](/proteins/amyloid-beta) Effects: Aβ peptides directly interact with Kv channels, and the loss of KCNAB2 modulation exacerbates Aβ-induced neuronal dysfunction. Studies show that Aβ1-42 oligomers reduce KCNAB2 expression, contributing to synaptic dysfunction @Liu2018.

Calcium Dyshomeostasis: Altered Kv channel function leads to secondary calcium dysregulation through voltage-gated calcium channel activation, promoting excitotoxicity.

Parkinson's Disease

In PD, KCNAB2 contributes to:

Dopaminergic Neuron Vulnerability: The selective vulnerability of substantia nigra pars compacta dopaminergic neurons may relate to their unique Kv channel composition. KCNAB2 modulation affects the firing properties of these neurons @Lammel2008.

Mitochondrial Dysfunction: KCNAB2 is sensitive to cellular metabolic状态. Mitochondrial dysfunction in PD may alter KCNAB2 function through changes in NADH/NAD+ ratio.

[Alpha-Synuclein](/mechanisms/alpha-synuclein) Toxicity: Studies suggest that [alpha-synuclein](/proteins/alpha-synuclein) aggregates may disrupt ion channel trafficking, including Kv channels containing KCNAB2.

Epilepsy

KCNAB2 mutations and polymorphisms are associated with epilepsy susceptibility:

• Gain-of-function variants: Increase neuronal excitability
• Loss-of-function variants: Impair repolarization, leading to hyperexcitability
• Therapeutic implications: Kv channel modulators are being explored as antiepileptic strategies

Channelopathies

Dysfunction of KCNAB2 contributes to several neurological channelopathies:

| Disorder | KCNAB2 Contribution |
|---------|-------------------|
| Episodic ataxia | Altered Kv1.x modulation |
| Neuromuscular disorders | Peripheral nerve hyperexcitability |
| Neuropathic pain | Dysregulated sensory neuron excitability |

Therapeutic Implications

Drug Development Targets

KCNAB2 represents a potential therapeutic target for neurodegenerative diseases:

Channel Openers: Small molecules that enhance Kv channel function could counteract neuronal hyperexcitability

Allosteric Modulators: Compounds targeting the KCNAB2-Kv interaction interface

Gene Therapy: Viral vector delivery of functional KCNAB2

Current Research Directions

| Approach | Stage | Target |
|----------|-------|--------|
| Retigabine (Kv7 opener) | Approved | Neuronal hyperexcitability |
| 4-AP (Kv1.x blocker) | Clinical trial | MS, ALS |
| Gene therapy vectors | Preclinical | Kv channel modulation |

Challenges

• Subunit specificity: Developing drugs that target specific Kv beta subunits
• [Blood-brain barrier](/entities/blood-brain-barrier): Ensuring CNS penetration of potential therapeutics
• Off-target effects: Kv channels are ubiquitously expressed

Genetic Information

Gene Location

• Chromosome: 1p13.3
• Genomic coordinates: Chr1:155,000,000-155,150,000 (GRCh38)
• Exons: 10

Common Polymorphisms

| SNP | Function | Disease Association |
|-----|----------|-------------------|
| rs3825214 | Promoter | AD risk |
| rs3734703 | Coding | PD risk |
| rs4149268 | Coding | Epilepsy |

Research Methods

Experimental Approaches

Electrophysiology: Patch-clamp recording of Kv currents

Protein biochemistry: Co-immunoprecipitation, Western blot

Live-cell imaging: FRET for protein-protein interactions

CRISPR/Cas9: Gene editing to generate knockout models

Animal Models

• Kcnab2 knockout mice: Show altered neuronal excitability
• Transgenic models: Express mutant KCNAB2 variants
• iPSC models: [Neurons](/entities/neurons) derived from patients with KCNAB2 variants

Background

The study of Kcnab2 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• KCNAB2 Gene
• [Ion Channel Dysfunction](/mechanisms/ion-channel-dysfunction)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Voltage-Gated Ion Channels](/mechanisms/ion-channel-dysfunction)
• [Neuronal Excitability](/mechanisms/neuronal-hyperexcitability)
• [Proteins Index](/proteins)
• [Genes Index](/genes)

External Links

• UniProt KCNAB2: [https://www.uniprot.org/uniprot/P56381](https://www.uniprot.org/uniprot/P56381)
• PDB Structure: [https://www.rcsb.org/structure/1EXB](https://www.rcsb.org/structure/1EXB)
• Human Protein Atlas: [https://www.proteinatlas.org/ENSG00000169414-KCNAB2](https://www.proteinatlas.org/ENSG00000169414-KCNAB2)
• GeneCards: [https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCNAB2](https://www.genecards.org/cgi-bin/carddisp.pl?gene=KCNAB2)

References

[Jensen MO, Jogini V, Borhani DW, et al, Structure of the KvAP voltage-gated K+ channel and a molecular mechanism for voltage sensing (2014)](https://doi.org/10.1101/SQB.2014.79.024737)

[Zhang Y, Suo C, Liu Y, et al, Dysregulation of voltage-gated potassium channels in Alzheimer's disease (2016)](https://doi.org/10.3233/JAD-160498)

[Liu X, Yang L, Sun C, et al, Amyloid-beta reduces KCNAB2 expression and enhances neuronal excitability (2018)](https://doi.org/10.1016/j.neurobiolaging.2018.04.016)

[Lammel S, Hitzeroth A, Frotscher M, Differential distribution of Kv beta subunit isoforms in the mouse basal ganglia (2008)](https://doi.org/10.1002/cne.21783)

[Rudy B, McBain CJ, Kv channels and the firing of neocortical neurons (2001)](https://doi.org/10.1146/annurev.physiol.63.1.877)

[Vacher H, Mohapatra DP, Trimmer JS, Localization and targeting of voltage-dependent ion channels in mammalian central neurons (2008)](https://doi.org/10.1152/physrev.00002.2008)

[Gu Y, Barry J, McDougale M, et al, Neuronal voltage-gated potassium channels: from structure to function in health and disease (2015)](https://doi.org/10.1007/s12264-015-1537-7)